Coloplast AS (COLO B) - Financial and Strategic SWOT Analysis Review
January 2019
50
About the Report
About the Report
Coloplast AS (COLO B)-Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:
- Business description-A detailed description of the company's operations and business divisions.
- Corporate strategy-Analyst's summarization of the company's business strategy.
- SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.
- Company history-Progression of key events associated with the company.
- Major products and services-A list of major products, services and brands of the company.
- Key competitors-A list of key competitors to the company.
- Key employees-A list of the key executives of the company.
- Executive biographies-A brief summary of the executives' employment history.
- Key operational heads-A list of personnel heading key departments/functions.
- Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities-A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights
Coloplast A/S (Coloplast) provides products and services for ostomy care, urology care, continence care, and skin and wound care. Its major products include ostomy bags; urisheaths; urine bags; catheters; anal irrigation systems; vaginal sling products; advanced foam dressings and hydrocolloid dressings for infected, non-infected and painful wounds; cleansers; moisturizers; skin protectants; anti-fungals; and hand cleansers. It also offers a wide range of disposable products to support endourological and percutaneous procedures, prostate disorders, laparoscopic procedures, and testicular prosthesis. Coloplast supplies its products through subsidiaries and distributors to hospitals, institutions, wholesalers and retailers in Europe, Asia-Pacific and North America. Coloplast is headquartered in Humlebaek, Denmark.
Coloplast AS Key Recent Developments
Nov 12,2018: Paul Marcun returns to Coloplast as a member of the Executive Management team and new Executive Vice President of Chronic Care
Nov 01,2018: Lars Rasmussen resigns his position as CEO of Coloplast
Nov 01,2018: Coloplast delivers solid full-year result and 8% growth for the sixth quarter running
Aug 08,2018: Coloplast delivers 8% growth and upgrades full-year growth guidance
May 03,2018: Coloplast delivers 8% organic revenue growth and upgrades full-year growth expectations
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
Products
Companies
Rochester Medical Ltd.
Molnlycke Health Care AB
Hollister Inc
ConvaTec Group Plc
C. R. Bard Inc
B. Braun Melsungen AG
Table of Contents
Table of Contents
Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Section 1-About the Company 6
Coloplast A/S-Key Facts 6
Coloplast A/S-Key Employees 7
Coloplast A/S-Key Employee Biographies 8
Coloplast A/S-Major Products and Services 9
Coloplast A/S-History 12
Coloplast A/S-Company Statement 15
Coloplast A/S-Locations And Subsidiaries 16
Head Office 16
Other Locations & Subsidiaries 16
Section 2-Company Analysis 19
Company Overview 19
Coloplast A/S-Business Description 20
Business Segment: Chronic Care 20
Overview 20
Performance 20
Business Segment: Interventional Urology 20
Overview 20
Performance 20
Business Segment: Wound & Skin Care 21
Overview 21
Performance 21
Geographical Segment: Emerging Markets 21
Performance 21
Geographical Segment: European Markets 21
Target Markets 21
Performance 21
Geographical Segment: Other developed markets 21
Performance 21
R&D Overview 21
Coloplast A/S-Corporate Strategy 22
Coloplast A/S-SWOT Analysis 23
SWOT Analysis-Overview 23
Coloplast A/S-Strengths 23
Coloplast A/S-Weaknesses 24
Coloplast A/S-Opportunities 25
Coloplast A/S-Threats 26
Coloplast A/S-Key Competitors 27
Section 3-Company Financial Ratios 28
Financial Ratios-Capital Market Ratios 28
Financial Ratios-Annual Ratios 29
Performance Chart 32
Financial Performance 32
Financial Ratios-Interim Ratios 33
Financial Ratios-Ratio Charts 34
Section 4-Company's Lifesciences Financial Deals and Alliances 35
Coloplast A/S, Medical Equipment, Deals By Year, 2013 to YTD 2019 35
Coloplast A/S, Medical Equipment, Deals By Type, 2013 to YTD 2019 36
Coloplast A/S, Recent Deals Summary 37
Section 5-Company's Recent Developments 38
Nov 12, 2018: Paul Marcun returns to Coloplast as a member of the Executive Management team and new Executive Vice President of Chronic Care 38
Nov 01, 2018: Lars Rasmussen resigns his position as CEO of Coloplast 39
Nov 01, 2018: Coloplast delivers solid full-year result and 8% growth for the sixth quarter running 40
Aug 08, 2018: Coloplast delivers 8% growth and upgrades full-year growth guidance 41
May 03, 2018: Coloplast delivers 8% organic revenue growth and upgrades full-year growth expectations 42
Feb 01, 2018: Coloplast delivers solid Q1 interim results and continues to take market share 44
Section 6-Appendix 46
Methodology 46
Ratio Definitions 46
About GlobalData 50
Contact Us 50
Disclaimer 50
List of Figure
List of Figures
Coloplast A/S, Performance Chart (2014-2018) 32
Coloplast A/S, Ratio Charts 34
Coloplast A/S, Medical Equipment, Deals By Year, 2013 to YTD 2019 35
Coloplast A/S, Medical Equipment, Deals by Type, 2013 to YTD 2019 36
List of Table
List of Tables
Coloplast A/S, Key Facts 6
Coloplast A/S, Key Employees 7
Coloplast A/S, Key Employee Biographies 8
Coloplast A/S, Major Products and Services 9
Coloplast A/S, History 12
Coloplast A/S, Other Locations 16
Coloplast A/S, Subsidiaries 16
Coloplast A/S, Key Competitors 27
Coloplast A/S, Ratios based on current share price 28
Coloplast A/S, Annual Ratios 29
Coloplast A/S, Annual Ratios (Cont...1) 30
Coloplast A/S, Annual Ratios (Cont...2) 31
Coloplast A/S, Interim Ratios 33
Coloplast A/S, Medical Equipment, Deals By Year, 2013 to YTD 2019 35
Coloplast A/S, Medical Equipment, Deals By Type, 2013 to YTD 2019 36
Coloplast A/S, Recent Deals Summary 37
Currency Codes 46
Capital Market Ratios 46
Equity Ratios 47
Profitability Ratios 47
Cost Ratios 48
Liquidity Ratios 48
Leverage Ratios 49
Efficiency Ratios 49
Why Buy From US?
What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story
We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.
While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.
With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.
Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.
If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.